EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The Internal Nanostructure of Lipid Nanoparticles Influences Their Diverse Cellular Uptake Pathways

Sue Lyn Yap, Brendan Dyett, Alison J Hobro, Han Nguyen, Nicholas I Smith, Calum J Drummond, Charlotte E Conn, Nhiem Tran iD

Small · 2025-10 · 21 (40)

DOI: 10.1002/smll.202500903 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 20.05.2025. Verfasst von Sue Lyn Yap und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Science, STEM College, RMIT University, Melbourne, Victoria, 3000, Australia. Hauptthemen laut MEDLINE: Nanoparticles, Nanostructures, Lipids. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid nanoparticles have emerged as critical platforms for bioactive agent delivery, with their success in COVID‐19 vaccines highlighting the urgent need to address gaps in understanding their biological interactions. Lyotropic liquid crystalline nanoparticles (LLCNPs) represent promising nanocarriers for bioactive agent delivery. In this study, it is revealed for the first time how internal nanostructures of LLCNPs – liposomes, cubosomes, hexosomes, and micellar cubosomes – influence their cellular uptake pathways. By isolating the effects of mesophase while maintaining consistent particle size, charge, and surface coating, it is demonstrated that non‐lamellar LLCNPs, particularly cubosomes, significantly enhance cellular uptake via distinct endocytic and non‐endocytic mechanisms. These nanoparticles predominantly utilize passive non‐endocytic pathways, such as membrane fusion, bypassing endocytic recycling challenges faced by most nanomaterials, including lamellar liposomes. Among active endocytic pathways, macropinocytosis emerges as the dominant route for non‐lamellar particles. The findings establish a direct link between LLCNP internal nanostructure and cellular internalization mechanisms, highlighting the critical role of mesophase design in optimizing nanocarrier performance. This knowledge enables the rational engineering of LLCNPs tailored to target specific uptake pathways, facilitating precision delivery for diverse therapeutic applications and addressing key barriers in intracellular drug transport.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesNanostructuresLipidsHumansEndocytosisLiposomesParticle SizeLiquid CrystalsPinocytosis

Stichwörter der Autor:innen

cell uptakecubosomesendocytosislipid nanoparticlesmembrane fusion

Substanzen

LiposomesLipid NanoparticlesLipids

Autor:innen und Institutionen

  • School of Science, STEM College, RMIT University, Melbourne, Victoria, 3000, Australia.
  • Biophotonics Laboratory, Immunology Frontier Research Center, Osaka University, Suita, Osaka, 5650871, Japan.

ORCID-Profile: Nhiem Tran

Zitieren

APA

Yap, S. L., Dyett, B., Hobro, A. J., Nguyen, H., Smith, N. I., Drummond, C. J., Conn, C. E., & Tran, N. (2025). The Internal Nanostructure of Lipid Nanoparticles Influences Their Diverse Cellular Uptake Pathways. Small, 21(40). https://doi.org/10.1002/smll.202500903

Vancouver

Yap SL, Dyett B, Hobro AJ, Nguyen H, Smith NI, Drummond CJ, et al. The Internal Nanostructure of Lipid Nanoparticles Influences Their Diverse Cellular Uptake Pathways. Small. 2025;21(40). doi:10.1002/smll.202500903

BibTeX
@article{Yap2025,
  author = {Yap, Sue Lyn and Dyett, Brendan and Hobro, Alison J and Nguyen, Han and Smith, Nicholas I and Drummond, Calum J and Conn, Charlotte E and Tran, Nhiem},
  title = {The Internal Nanostructure of Lipid Nanoparticles Influences Their Diverse Cellular Uptake Pathways},
  journal = {Small},
  year = {2025},
  volume = {21},
  number = {40},
  doi = {10.1002/smll.202500903}
}
Kostenlos starten →